arrow
C

Cynthia A. Moylan

Department of Medicine
H指数:31
被引数:5,327

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Metabolic markers of kidney function and oxidative stress are associated with heart failure with preserved ejection fraction (HFpEF) in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD)

代谢功能障碍相关脂肪性肝病(MASLD)患者中,肾功能和氧化应激的代谢标志物与射血分数保留的心力衰竭(HFpEF)相关

2026-04-290
OA
Lessons learned from viral hepatitis testing that inform law and policy responses to steatotic liver disease

从病毒性肝炎检测中吸取的经验教训,为法律和政策应对脂肪性肝病提供信息

2026-01-300
PRE
Practice Changing RCT Design and Rationale: Abbreviated MRI plus AFP vs ultrasound plus AFP for HCC surveillance in cirrhosis (PREMIUM study)

实践变革RCT设计与原理:缩写MRI联合AFP与超声联合AFP用于肝硬化肝癌筛查(PREMIUM研究)

2025-11-060
OAAI
Osteopontin Promotes Cholangiocyte Secretion of Chemokines to Support Macrophage Recruitment and Fibrosis in MASH

骨桥蛋白促进胆管细胞分泌趋化因子支持巨噬细胞募集和纤维化

2024-10-180
OA
Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot study

maralixibat在原发性硬化性胆管炎成人患者中的安全性,耐受性和有效性: 开放标签试点研究

2023-06-0117
OAAI